发明名称 |
Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F |
摘要 |
The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules. |
申请公布号 |
US2015322147(A1) |
申请公布日期 |
2015.11.12 |
申请号 |
US201514706234 |
申请日期 |
2015.05.07 |
申请人 |
UCB Pharma S.A. |
发明人 |
Adams Ralph;Popplewell Andrew George;Rapecki Stephen Edward |
分类号 |
C07K16/24;A61K39/395 |
主分类号 |
C07K16/24 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating an IL-17A and/or IL-17F mediated pathological condition in a mammal comprising the step of administering to the mammal a therapeutically effective amount of a pharmaceutical composition comprising a neutralising antibody which binds human IL-17A and human IL-17F, wherein the neutralising antibody cross-blocks the binding of an antibody that binds human IL-17A and human IL-17F and has a heavy chain comprising sequence given in SEQ ID NOs:9 or 15 and a light chain comprising sequence given in SEQ ID NOs:7 or 11 to human IL-17A and/or human IL-17F and/or IL-17A/F heterodimer and/or is cross-blocked from binding human IL-17A and/or human IL-17F and/or IL-17A/F heterodimer by the antibody that binds human IL-17A and human IL-17F and has the heavy chain comprising sequence given in SEQ ID NOs:9 or 15 and the light chain comprising sequence given in SEQ ID NOs:7 or 11, in combination with one or more pharmaceutically acceptable excipients, diluents or carriers. |
地址 |
Brussels BE |